Literature DB >> 19624502

Detection and characterization of Enterobacteriaceae producing metallo-beta-lactamases in a tertiary-care hospital in Spain.

E Cendejas1, R Gómez-Gil, P Gómez-Sánchez, J Mingorance.   

Abstract

Carbapenem-resistant or intermediate (MIC >or=1 mg/L) clinical isolates (n = 12) of three species of Enterobacteriaceae (Klebsiella pneumoniae, Klebsiella oxytoca and Escherichia coli) were characterized. The isolates harboured integrons containing the VIM-1 metallo-beta-lactamase gene together with other resistance gene cassettes. In particular, the CTX-M-2 gene was detected in four of the K. pneumoniae isolates. The patient population was mostly paediatric and characterized by severe underlying illnesses that involved long-term hospitalization, major surgery and/or immunosuppressive and broad-spectrum antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624502     DOI: 10.1111/j.1469-0691.2009.02888.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.

Authors:  G Valenza; S Müller; C Schmitt; D Turnwald; T-T Lam; M Frosch; M Abele-Horn; Y Pfeifer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-27       Impact factor: 3.267

2.  Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients.

Authors:  Desirèe Gijón; Tânia Curiao; Fernando Baquero; Teresa M Coque; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

3.  Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

Authors:  Isabel Sánchez-Romero; Angel Asensio; Jesús Oteo; María Muñoz-Algarra; Beatriz Isidoro; Ana Vindel; José Alvarez-Avello; Bárbara Balandín-Moreno; Oscar Cuevas; Sara Fernández-Romero; Luisa Azañedo; David Sáez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Authors:  Kathleen Chiotos; Jennifer H Han; Pranita D Tamma
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

5.  Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.

Authors:  Moran G Goren; Shiri Navon-Venezia; Inna Chmelnitsky; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

6.  Structural Diversity of Class 1 Integrons in Multiresistant Strains of Escherichia coli Isolated from Patients in a Hospital in Mexico City.

Authors:  Gabriel Acosta-Pérez; Gabriela Ibáñez-Cervantes; Juan Manuel Bello-López; José Manuel Hernández; Zahuiti Hernández-Montañez; Silvia Giono-Cerezo; Gregorio León-García; Gloria León-Avila
Journal:  Curr Microbiol       Date:  2015-07-23       Impact factor: 2.188

7.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129

8.  Community-Onset Bloodstream and Other Infections, Caused by Carbapenemase-Producing Enterobacteriaceae: Epidemiological, Microbiological, and Clinical Features.

Authors:  José Ramón Paño-Pardo; Beatriz López Quintana; Fernando Lázaro Perona; Guillermo Ruiz Carrascoso; María Pilar Romero-Gómez; Belén Loeches Yagüe; Beatriz Díaz-Pollán; Ana Martínez-Virto; Jesús Mingorance; Julio García Rodríguez; José Ramón Arribas; Rosa Gómez-Gil
Journal:  Open Forum Infect Dis       Date:  2016-08-01       Impact factor: 3.835

9.  Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla NDM-5 in Escherichia coli ST405 Clinical Isolate in Japan.

Authors:  Yoko Takayama; Tsuyoshi Sekizuka; Hidehito Matsui; Yuzuru Adachi; Ryotaro Eda; Shin Nihonyanagi; Tatsuhiko Wada; Mari Matsui; Satowa Suzuki; Masashi Takaso; Hidero Kitasato; Makoto Kuroda; Hideaki Hanaki
Journal:  Infect Drug Resist       Date:  2020-02-18       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.